Who
David E. Lazar
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Aterian; Chief Executive Officer, Quantum Cyber; Chief Executive Officer, Sow Good; Director, Indaptus Therapeutics; Chief Executive Officer, Kala Bio; 10% owner, NovaBay Pharmaceuticals; Interim CEO, Bio Green Med Solution; President, LQR House.
In numbers
- Trades disclosed
- 87
- Buys
- 3
- Sells
- 4
- Bought
- $2.0M
- Sold
- $5.9M
- Companies
- 11
- Companies where not an officer
- 3
- First trade
- 6 Jul 2022
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | ATER Aterianoption or derivative · Electrical Equipment & Grid | SEC FORM 4 Code S | $11.7M1,750,000 at $6.70 | filing |
| 25 Sep 2026filed 29 Sep 2026 | ATER Aterianoption or derivative · Electrical Equipment & Grid | SEC FORM 4 Code S | $270K706,100 at $0.382 | filing |
| 25 Sep 2026filed 29 Sep 2026 | ATER Aterianoption or derivative · Electrical Equipment & Grid | SEC FORM 4 Code S | $11.7M1,750,000 at $6.70 | filing |
| 25 Sep 2026filed 29 Sep 2026 | ATER Aterianoption or derivative · Electrical Equipment & Grid | SEC FORM 4 Code S | $268K706,100 at $0.38 | filing |
| 24 Sep 2026filed 29 Sep 2026 | ATER AterianElectrical Equipment & Grid | SEC FORM 4 Code C | —1,300,530 at $0.00 | filing |
| 24 Sep 2026filed 29 Sep 2026 | ATER Aterianoption or derivative · Electrical Equipment & Grid | SEC FORM 4 Code C | —168,900 at $0.00 | filing |
| 24 Sep 2026filed 29 Sep 2026 | ATER Aterianoption or derivative · Electrical Equipment & Grid | SEC FORM 4 Code C | —168,900 at $0.00 | filing |
| 24 Sep 2026filed 29 Sep 2026 | ATER AterianElectrical Equipment & Grid | SEC FORM 4 Code C | —1,300,530 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code C | $81.0M9,000,000 at $9.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code C | $81.0M9,000,000 at $9.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code C | $81.0M9,000,000 at $9.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,000,000 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,000,000 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,000,000 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —124,700 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code C | $6.3B28,057,500 at $225.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,000,000 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,000,000 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,000,000 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | QUCY Quantum Cyberoption or derivative · Biotechnology | SEC FORM 4 Code C | —124,700 at $0.00 | filing |
News
Head to Head Contrast: Target (NYSE:TGT) vs. LQR House (NASDAQ:YHC)YHC · dailypolitical.com · 21 Oct 2026Ashtead Group (OTCMKTS:ASHTY) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS) Critical ReviewBGMS · themarketsdaily.com · 18 Oct 2026Financial Contrast: LQR House (NASDAQ:YHC) and Sysco (NYSE:SYY)YHC · tickerreport.com · 18 Oct 2026LQR House (NASDAQ: YHC) names Leo Chen CEO as Dollinger steps downYHC · tickerreport.com · 17 Oct 2026Analyzing MIND C.T.I. (NASDAQ:MNDO) and Minim (NASDAQ:FIEE)FIEE · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name David E. Lazar; 5 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.